Here's some reasons to be hopeful that the early-stage life science sector is on the upswing. (though i am skeptical that the e-health ventures will deliver (in general.) investors are bringing dot-com growth expectations to regulated markets where behavior doesn't change fast. (And i'm speaking of consumer, practitioner, and payor behavior.)
Showing posts with label early stage. Show all posts
Showing posts with label early stage. Show all posts
Monday, September 24, 2012
Subscribe to:
Posts (Atom)